Gelatine Nanostructured Lipid Carrier Encapsulated FGF15 Inhibits Autophagy and Improves Recovery in Spinal Cord Injury

0
3
Many studies demonstrated that fibroblast growth factor therapies after spinal cord injury (SCI) could be used in the future for the recovery of neurons. The therapeutic effects of gelatine nanostructured lipid carriers-encapsulated fibroblast growth factor 15 (FGF15) and FGF15 were compared in SCI.
[Cell Death Discovery]
Ying, Y., Xiang, G., Chen, M., Ye, J., Wu, Q., Dou, H., Sheng, S., & Zhu, S. (2020). Gelatine nanostructured lipid carrier encapsulated FGF15 inhibits autophagy and improves recovery in spinal cord injury. Cell Death Discovery, 6(1), 1–11. https://doi.org/10.1038/s41420-020-00367-y Cite
Full Article